FDA Approves Nonhormonal Treatment for Menopausal Hot Flashes
The US Food and Drug Administration (FDA) recently approved elinzanetant, marketed as Lynkuet, for moderate to severe hot flashes due to menopause, the third FDA-approved nonhormonal treatment option for vasomotor symptoms, which include hot flashes and night sweats.
Authors
- Saumya Pant
Publication Details
- Journal
- JAMA
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1001/jama.2025.19735
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00